Travel advice for the immunocompromised traveler: Prophylaxis, vaccination, and other preventive measures

Rupa R. Patel, Stephen Y. Liang, Pooja Koolwal, Frederick Matthew Kuhlmann

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Immunocompromised patients are traveling at increasing rates. Physicians caring for these complex patients must be knowledgeable in pretravel consultation and recognize when referral to an infectious disease specialist is warranted. This article outlines disease prevention associated with international travel for adults with human immunodeficiency virus, asplenia, solid organ and hematopoietic transplantation, and other immunosuppressed states. While rates of infection may not differ significantly between healthy and immunocompromised travelers, the latter are at greater risk for severe disease. A thorough assessment of these risks can ensure safe and healthy travel. The travel practitioners’ goal should be to provide comprehensive risk information and recommend appropriate vaccinations or prevention measures tailored to each patient’s condition. In some instances, live vaccines and prophylactic medications may be contraindicated.

Original languageEnglish (US)
Pages (from-to)217-228
Number of pages12
JournalTherapeutics and Clinical Risk Management
Volume11
DOIs
StatePublished - Feb 12 2015
Externally publishedYes

Fingerprint

prophylaxis
vaccination
Vaccination
travel
Referral and Consultation
Disease
Vaccines
Immunocompromised Host
Organ Transplantation
Viruses
contagious disease
Communicable Diseases
medication
physician
HIV
Physicians
Infection

Keywords

  • Diarrhea
  • Immunocompromised
  • Malaria
  • Travel
  • Vaccines

ASJC Scopus subject areas

  • Safety Research
  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pharmacology (medical)
  • Chemical Health and Safety

Cite this

Travel advice for the immunocompromised traveler : Prophylaxis, vaccination, and other preventive measures. / Patel, Rupa R.; Liang, Stephen Y.; Koolwal, Pooja; Matthew Kuhlmann, Frederick.

In: Therapeutics and Clinical Risk Management, Vol. 11, 12.02.2015, p. 217-228.

Research output: Contribution to journalArticle

@article{2bc3daa67f1348a68fc9caca2e1f734c,
title = "Travel advice for the immunocompromised traveler: Prophylaxis, vaccination, and other preventive measures",
abstract = "Immunocompromised patients are traveling at increasing rates. Physicians caring for these complex patients must be knowledgeable in pretravel consultation and recognize when referral to an infectious disease specialist is warranted. This article outlines disease prevention associated with international travel for adults with human immunodeficiency virus, asplenia, solid organ and hematopoietic transplantation, and other immunosuppressed states. While rates of infection may not differ significantly between healthy and immunocompromised travelers, the latter are at greater risk for severe disease. A thorough assessment of these risks can ensure safe and healthy travel. The travel practitioners’ goal should be to provide comprehensive risk information and recommend appropriate vaccinations or prevention measures tailored to each patient’s condition. In some instances, live vaccines and prophylactic medications may be contraindicated.",
keywords = "Diarrhea, Immunocompromised, Malaria, Travel, Vaccines",
author = "Patel, {Rupa R.} and Liang, {Stephen Y.} and Pooja Koolwal and {Matthew Kuhlmann}, Frederick",
year = "2015",
month = "2",
day = "12",
doi = "10.2147/TCRM.S52008",
language = "English (US)",
volume = "11",
pages = "217--228",
journal = "Therapeutics and Clinical Risk Management",
issn = "1176-6336",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Travel advice for the immunocompromised traveler

T2 - Prophylaxis, vaccination, and other preventive measures

AU - Patel, Rupa R.

AU - Liang, Stephen Y.

AU - Koolwal, Pooja

AU - Matthew Kuhlmann, Frederick

PY - 2015/2/12

Y1 - 2015/2/12

N2 - Immunocompromised patients are traveling at increasing rates. Physicians caring for these complex patients must be knowledgeable in pretravel consultation and recognize when referral to an infectious disease specialist is warranted. This article outlines disease prevention associated with international travel for adults with human immunodeficiency virus, asplenia, solid organ and hematopoietic transplantation, and other immunosuppressed states. While rates of infection may not differ significantly between healthy and immunocompromised travelers, the latter are at greater risk for severe disease. A thorough assessment of these risks can ensure safe and healthy travel. The travel practitioners’ goal should be to provide comprehensive risk information and recommend appropriate vaccinations or prevention measures tailored to each patient’s condition. In some instances, live vaccines and prophylactic medications may be contraindicated.

AB - Immunocompromised patients are traveling at increasing rates. Physicians caring for these complex patients must be knowledgeable in pretravel consultation and recognize when referral to an infectious disease specialist is warranted. This article outlines disease prevention associated with international travel for adults with human immunodeficiency virus, asplenia, solid organ and hematopoietic transplantation, and other immunosuppressed states. While rates of infection may not differ significantly between healthy and immunocompromised travelers, the latter are at greater risk for severe disease. A thorough assessment of these risks can ensure safe and healthy travel. The travel practitioners’ goal should be to provide comprehensive risk information and recommend appropriate vaccinations or prevention measures tailored to each patient’s condition. In some instances, live vaccines and prophylactic medications may be contraindicated.

KW - Diarrhea

KW - Immunocompromised

KW - Malaria

KW - Travel

KW - Vaccines

UR - http://www.scopus.com/inward/record.url?scp=84922992101&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922992101&partnerID=8YFLogxK

U2 - 10.2147/TCRM.S52008

DO - 10.2147/TCRM.S52008

M3 - Article

C2 - 25709464

AN - SCOPUS:84922992101

VL - 11

SP - 217

EP - 228

JO - Therapeutics and Clinical Risk Management

JF - Therapeutics and Clinical Risk Management

SN - 1176-6336

ER -